Patheon Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
- Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company.
Patheon Inc (Patheon), a part of DPx Holdings BV, is a contract manufacturing and contract development service provider. The company’s services ranges from preclinical development to commercial manufacturing of a wide array of solid and sterile dosage forms. Its broad range of fully integrated pharmaceutical development services comprises pre-formulation, formulation, clinical manufacturing, analytical development, scale-up and commercialization. Patheon operates through an integrated development and manufacturing network of manufacturing facilities and development centers across North America and Europe. It provides its services to pharmaceutical and biotechnology companies across the world. It is headquartered in Durham, North Carolina, the US.
Patheon Inc Key Recent Developments
Oct 11, 2016: Patheon Announces the Retirement of Stuart Grant Jul 05, 2016: Patheon Names Patrick Glaser Senior Vice President for Small Molecule API Business May 31, 2016: Patheon Appoints Michel Lagarde as President Mar 14, 2016: Patheon Signs Flexible Manufacturing Agreement with Amgen Feb 22, 2016: Patheon Selected by Grünenthal to Develop Drugs Using INTAC Abuse Deterrent Formulations Technology
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. - Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy. - Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company. - Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Patheon Inc - Strategic SWOT Analysis Review Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Section 1 - About the Company 5 Patheon Inc - Key Facts 5 Patheon Inc - Key Employees 6 Patheon Inc - Key Employee Biographies 7 Patheon Inc - Major Products and Services 8 Patheon Inc - History 10 Patheon Inc - Company Statement 14 Patheon Inc - Locations And Subsidiaries 15 Head Office 15 Other Locations and Subsidiaries 15 Section 2 - Company Analysis 19 Patheon Inc - Business Description 19 Patheon Inc - Corporate Strategy 20 Patheon Inc - SWOT Analysis 21 SWOT Analysis - Overview 21 Patheon Inc - Strengths 21 Patheon Inc - Weaknesses 22 Patheon Inc - Opportunities 23 Patheon Inc - Threats 24 Patheon Inc - Key Competitors 25 Section 3 - Company's Lifesciences Financial Deals and Alliances 26 Patheon Inc, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 26 Patheon Inc, Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 27 Patheon Inc, Recent Deals Summary 28 Section 4 - Company's Recent Developments 29 Oct 11, 2016: Patheon Announces the Retirement of Stuart Grant 29 Jul 05, 2016: Patheon Names Patrick Glaser Senior Vice President for Small Molecule API Business 30 May 31, 2016: Patheon Appoints Michel Lagarde as President 31 Mar 14, 2016: Patheon Signs Flexible Manufacturing Agreement with Amgen 32 Feb 22, 2016: Patheon Selected by GrÃ¼nenthal to Develop Drugs Using INTAC Abuse Deterrent Formulations Technology 33 Feb 08, 2016: Patheon Appoints Andrew G. Long as Senior Vice President and Global Business Controller 34 Feb 02, 2016: Patheon Appoints Leader for Biologics 35 Jan 11, 2016: Life Sciences Executive to Join Patheon 36 Oct 22, 2015: Patheon to Highlight Solubility Solutions and Patheon OneSource at 2015 AAPS Annual Meeting and Exposition 37 Sep 28, 2015: Patheon Unveils New Brand and Identity 38 Section 5 - Appendix 39 Methodology 39 About GlobalData 39 Contact Us 39 Disclaimer 39
List of Tables Patheon Inc, Key Facts 5 Patheon Inc, Key Employees 6 Patheon Inc, Key Employee Biographies 7 Patheon Inc, Major Products and Services 8 Patheon Inc, History 10 Patheon Inc, Other Locations 15 Patheon Inc, Subsidiaries 16 Patheon Inc, Key Competitors 25 Patheon Inc, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 26 Patheon Inc, Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 27 Patheon Inc, Recent Deals Summary 28
List of Figures Patheon Inc, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 26 Patheon Inc, Pharmaceuticals and Healthcare, Deals by Type, 2010 to YTD 2016 27